Results 151 to 160 of about 39,565,656 (306)

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Perivascular Adipose Tissue Angiotensin II Type 1 Receptor Promotes Vascular Inflammation and Aneurysm Formation

HYPERTENSION, 2017
Tomoki Sakaue, J. Suzuki, Mika Hamaguchi, Chika Suehiro, A. Tanino, Tomoaki Nagao, T. Uetani, J. Aono, Hirotomo Nakaoka, M. Kurata, Tomohisa Sakaue, T. Okura, Takumi Yasugi, H. Izutani, J. Higaki, Shuntaro Ikeda   +15 more
semanticscholar   +1 more source

Acute Urinary Bladder Distension Triggers Icam-1-Mediated Renal Oxidative Injury Via the Norepinephrine-Renin-Angiotensin Ii System in Rats

, 2011
Background/Purpose: Acute urinary bladder distension (AUBD) can activate bladder mechanical afferent and renal sympathetic nerves, which contributes to renal vasoconstriction.
陳壽星;陳旺全;李秉家;鄭劍廷, CHEN, SHOW-SHING;CHEN, WANG-CHUAN;LI, PING-CHIA;CHIEN, CHIANG-TING   +1 more
core  

Angiotensin Ii Does Not Influence Expression of Sarcoplasmic Reticulum Ca2 + Atpase in Atrial Myocytes

, 2011
Introduction. The sarcoplasmic reticulum Ca2+ ATPase (SERCA) is essential for the regulation of the intracellular calcium level in cardiomyocytes. Previous studies have found that angiotensin 11 (Ang II) decreased SERCA2 gene expression in ventricular ...
吳卓鍇;曾春典;黃尹岑;謝佳珊;蔡維珊;林俊立;江福田;蔡佳醍, WU, CHO-KAI;TSENG, CHUEN-DEN;HUANG, YIN-TSEN;HSIEH, CHIA-SHAN;TSAI, WEI-SHAN;LIN, JIUNN-LEE;CHIANG, FU-TIEN;TSAI, CHIA-TI   +1 more
core   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Sparsentan, a Dual Endothelin Type A and Angiotensin II Subtype 1 Receptor Antagonist for the Treatment of Immunoglobulin A Nephropathy: Latest Trial Results, Pharmacokinetic Considerations, and Binding Profile

Immunoglobulin A nephropathy (IgAN) is one of the most common forms of primary glomerulonephritis. In some patients, it can progress rapidly, leading to proteinuria, kidney failure, and death.
Eleanor Roberts
core   +1 more source

Implementation of guideline‐recommended medical therapy for patients with heart failure in Europe

ESC Heart Failure, Volume 12, Issue 2, Page 790-798, April 2025.
Abstract Physicians' adherence to guideline‐recommended heart failure (HF) treatment remains suboptimal, especially regarding the target doses. In particular, there is evidence that non‐cardiologists are less compliant with HF guideline recommendations. This is likely to have a detrimental impact on patients' survival, readmissions and quality of life.
Maurizio Volterrani, Petar Seferovic, Gianluigi Savarese, Ilaria Spoletini, Egidio Imbalzano, Antoni Bayes‐Genis, Ewa Jankowska, Michele Senni, Marco Metra, Ovidiu Chioncel, Andrew J. S. Coats, Giuseppe M. C. Rosano   +11 more
wiley   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Telmisartan reduces systemic inflammation and alters the renin-angiotensin system in mild COVID-19

Scientific Reports
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, a respiratory viral infection that disrupts renin angiotensin system (RAS) peptide metabolism by downregulating angiotensin converting enzyme-II (ACE2), leading to accumulation
Angela Lu, Melissa Agsalda-Garcia, Weiyuan Hu, Catherine Chester, Aditya Anil Naik, Brooks I. Mitchell, Isaac Asante, Scott A. Souza, Kuo-Chiang Lian, Zao Zhang, Hannah V. Schmitz, Malia L. Ramirez, Richa Varshney, Serena DelMundo, Dominic C. Chow, Cecilia M. Shikuma, Stan G. Louie   +16 more
doaj   +1 more source

Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation.

Journal of the American College of Cardiology, 2003
K. Kumagai, H. Nakashima, H. Urata, N. Gondo, Kikuo Arakawa, K. Saku   +5 more
semanticscholar   +1 more source